Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: Ampio pharmaceuticals org | Vintage Vibes

Ampio Pharmaceuticals: Q1 Earnings Insights

Ampio Pharmaceuticals (AMEX:AMPE) reported its Q1 earnings results on Monday, May 16, 2022 at 04:10 PM. Here's what investors need to know about the announcement.

Benzinga · May 16, 2022

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 236 companies hit new 52-week lows.

Benzinga · Apr 21, 2022

Earnings Preview For Ampio Pharmaceuticals

Ampio Pharmaceuticals (AMEX:AMPE) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Ampio Pharmaceuticals will report an earnings per share (EPS) of $-0.02.

Benzinga · Mar 28, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022

Upgrades

Benzinga · Mar 24, 2022

Why Ampio Pharmaceuticals Stock Is Rising Today

Ampio Pharmaceuticals Inc (AMEX:AMPE) shares are trading significantly higher Thursday following bullish analyst coverage. Alliance Global Partners analyst James Molloy initiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a $4.50 price target, which is well above current levels.

Benzinga · Mar 24, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Oncology

329 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.